• HR+/HER2 neg2
• HER2+2
• TNBC2

• Protocols

• UW16106

  OPEN TO ACCRUAL

  Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
  
  

• UW20100

  OPEN TO ACCRUAL

  Ph II Pre-Op Neratinib + Endocrine Therapy w/ Trastuzumab in Triple-Positive Breast Cancers
  
  

• A012103

  OPEN TO ACCRUAL

  OptimICE-PCR Adjuvant TNBC de-escalation of therapy